SecurityPSI / PowerShares Exchange-Trade Fund Trust (73935X781)
Institutional Owners9
Institutional Shares108,856
Institutional Value$ 5,716,000 USD

Institutional Stock Ownership and Shareholders

PSI / PowerShares Exchange-Trade Fund Trust Institutional Ownership

PowerShares Exchange-Trade Fund Trust (NYSE:PSI) has 9 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 108,856 shares. Largest shareholders include Ladenburg Thalmann Financial Services Inc, Blackhawk Capital Partners Llc., National Asset Management, Inc., Commonwealth Equity Services, Inc, Citigroup Inc, Riggs Asset Managment Co. Inc., Clarus Wealth Advisors, WFG Advisors, LP, and MetLife Securities, Inc.
PowerShares Exchange-Trade Fund Trust (NYSE:PSI) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 211,317 0 -100.00 11,168 0 -100.00
2018-07-31 13F-HR Allianz Life Insurance Co Of North America 5,350 0 -100.00 283 0 -100.00
2018-08-14 13F-HR MORGAN STANLEY 294,476 0 -100.00 15,563 0 -100.00
2018-08-10 13F-HR CITIGROUP INC 1,677 0 -100.00 89 0 -100.00
2018-07-20 13F-HR Creative Planning 5,467 0 -100.00 289 0 -100.00
2018-08-10 13F-HR Calton & Associates, Inc. 12,031 0 -100.00 636 0 -100.00
2018-08-14 13F-HR Rainier Group Investment Advisory LLC 150 0 -100.00 8 0 -100.00
2018-08-13 13F-HR MML INVESTORS SERVICES, LLC 25,607 0 -100.00 1,353 0 -100.00
2018-08-07 13F-HR IFP Advisors, Inc 480 0 -100.00 25 0 -100.00
2018-05-11 13F-HR CITIGROUP INC 1,677 1,677 0.00 85 89 4.71
2018-07-31 13F-HR Commonwealth Equity Services, Llc. 32,157 0 -100.00 1,699 0 -100.00
2018-08-13 13F-HR Peak Capital Management Llc 212 0 -100.00 11 0 -100.00
2018-08-13 13F-HR HONKAMP KRUEGER FINANCIAL SERVICES INC /ADV 565 0 -100.00 30 0 -100.00
2018-08-14 13F-HR EDMOND DE ROTHSCHILD HOLDING S.A. 480 0 -100.00 25 0 -100.00
2018-08-14 13F-HR 1832 Asset Management L.P. 31,059 0 -100.00 1,649 0 -100.00
2018-08-14 13F-HR AMERIPRISE FINANCIAL INC 9,184 0 -100.00 484 0 -100.00
2018-08-14 13F-HR Cetera Advisor Networks LLC 8,515 0 -100.00 448 0 -100.00
2018-08-08 13F-HR US BANCORP \DE\ 2,571 0 -100.00 136 0 -100.00
2018-08-09 13F-HR Private Advisor Group, LLC 8,684 0 -100.00 459 0 -100.00
2018-08-13 13F-HR Stratos Wealth Partners, LTD. 45 0 -100.00 2 0 -100.00
2018-08-14 13F-HR Sensato Investors LLC 63,506 0 -100.00 3,356 0 -100.00
2018-08-14 13F-HR ROYAL BANK OF CANADA 120,536 0 -100.00 6,371 0 -100.00
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 18,351 0 -100.00 970 0 -100.00
2018-08-14 13F-HR STIFEL FINANCIAL CORP 14,971 0 -100.00 789 0 -100.00
2018-08-14 13F-HR Venturi Wealth Management, LLC 10,000 0 -100.00 529 0 -100.00
2018-07-30 13F-HR Parallel Advisors, LLC 146 0 -100.00 8 0 -100.00
2018-08-13 13F-HR Advisor Group, Inc. 5,033 0 -100.00 267 0 -100.00
2018-08-14 13F-HR/A CITADEL ADVISORS LLC 6,296 0 -100.00 333 0 -100.00
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 4,102 203
2018-08-14 13F-HR Northstar Wealth Partners LLC 30,179 0 -100.00 1,595 0 -100.00
2018-08-14 13F-HR Tower Research Capital LLC (TRC) 28,356 0 -100.00 1,499 0 -100.00
2018-08-14 13F-HR BARCLAYS PLC 2,420 0 -100.00 128 0 -100.00
2018-08-03 13F-HR Financial Architects, Inc 1,982 0 -100.00 105 0 -100.00
2018-07-27 13F-HR Riggs Asset Managment Co. Inc. 1,378 1,378 0.00 73 72 -1.37
2018-08-14 13F-HR VALLEY NATIONAL ADVISERS INC 251 0 -100.00 13 0 -100.00
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 480 0 -100.00 25 0 -100.00
2018-08-10 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 12,368 0 -100.00 654 0 -100.00
2018-08-01 13F-HR Wagner Wealth Management, Llc 14 0 -100.00 1 0 -100.00
2018-08-13 13F-HR Westside Investment Management, Inc. 90 0 -100.00 4,585 0 -100.00
2018-08-10 13F-HR Cambridge Investment Research Advisors, Inc. 14,452 0 -100.00 764 0 -100.00
2018-08-10 13F-HR ENVESTNET ASSET MANAGEMENT INC 2,864 0 -100.00 150 0 -100.00
2018-08-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 79,006 79,006 0.00 4,175 4,175 0.00
2018-08-14 13F-HR HighTower Advisors, LLC 138,459 0 -100.00 7,321 0 -100.00
2018-05-15 13F-HR National Asset Management, Inc. 9,667 10,269 6.23 488 543 11.27
2018-08-14 13F-HR BECK CAPITAL MANAGEMENT, LLC 58,095 0 -100.00 3,070 0 -100.00
2018-07-18 13F-HR Professional Planning 10,996 0 -100.00 581 0 -100.00
2018-08-15 13F-HR JANE STREET GROUP, LLC 44,950 0 -100.00 2,376 0 -100.00
2018-08-01 13F-HR G&s Capital Llc 1,065 0 -100.00 56 0 -100.00
2018-08-14 13F-HR UBS Group AG 366,424 0 -100.00 19,366 0 -100.00
2018-08-10 13F-HR NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 228 0 -100.00 12 0 -100.00
2018-07-17 13F-HR Winslow, Evans & Crocker, Inc. 2,940 0 -100.00 155,276 0 -100.00
2018-08-08 13F-HR Whitener Capital Management, Inc. 30 0 -100.00 1 0 -100.00
2018-07-30 13F-HR Raymond James Financial Services Advisors, Inc. 111,898 0 -100.00 5,914 0 -100.00
2018-07-20 13F-HR North Star Investment Management Corp. 250 0 -100.00 13 0 -100.00
2018-08-14 13F-HR Resources Investment Advisors, Inc. 3,230 0 -100.00 171 0 -100.00
2018-08-14 13F-HR LPL Financial LLC 77,108 0 -100.00 4,075 0 -100.00
2018-08-03 13F-HR Seacrest Wealth Management, Llc 100 0 -100.00 5 0 -100.00
2018-08-02 13F-HR Sigma Planning Corp 6,741 0 -100.00 356 0 -100.00
2018-07-18 13F-HR Jackson Financial Management 38,630 0 -100.00 2,042 0 -100.00
2018-08-13 13F-HR Certified Advisory Corp 535 0 -100.00 28 0 -100.00
2018-07-19 13F-HR BENJAMIN F. EDWARDS & COMPANY, INC. 62 0 -100.00 3 0 -100.00
2018-08-14 13F-HR Hilltop Holdings Inc. 37,785 0 -100.00 1,996 0 -100.00
2018-07-05 13F-HR Clarus Wealth Advisors 750 40
2018-08-14 13F-HR Valeo Financial Advisors, Llc 192 0 -100.00 10 0 -100.00
2018-08-13 13F-HR RAYMOND JAMES & ASSOCIATES 79,469 0 -100.00 4,201 0 -100.00
2018-08-01 13F-HR Hudock Capital Group, LLC 1,964 0 -100.00 103 0 -100.00
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 23,523 0 -100.00 1,243 0 -100.00
2018-08-14 13F-HR Crow Point Partners, LLC 6,000 0 -100.00 317 0 -100.00
2017-01-13 13F-HR MetLife Securities, Inc 200 469 134.50 7 17 142.86
2018-08-14 13F-HR JP Morgan Chase & Co 784 0 -100.00 41 0 -100.00
2018-08-09 13F-HR Blackhawk Capital Partners Llc. 20,323 10,455 -48.56 1,074 546 -49.16
2018-08-14 13F-HR Parallax Volatility Advisers, L.P. 1 0 -100.00 0 0
2017-08-18 13F-HR WFG Advisors, LP 1,500 750 -50.00 63 31 -50.79

Related Articles

DMPI: DelMar Pharmaceuticals Analysis and Research Report

19h - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

CUSIP: 73935X781